TCG Crossover Management »

Astria Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $25M 2.8M 9.10
2024-03-31 $74M 5.3M 14.08

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Astria Therapeutics

Perceptive Advisors
RA Capital Management
VR Adviser
Fairmount Funds Management
BlackRock
Vestal Point Capital
TCG Crossover Management
Vanguard Group
State Street Corporation
Millennium Management
Driehaus Capital Management
Citadel Advisors
Geode Capital Management
Affinity Asset Advisors
Nantahala Capital Management

View all funds holding Astria Therapeutics